| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
127,470,000 |
| Market
Cap: |
1.66(B) |
| Last
Volume: |
878,666 |
Avg
Vol: |
1,074,261 |
| 52
Week Range: |
$11.665 - $20.73 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile NeoGenomics operate a network of cancer-focused testing laboratories in the U.S., Europe and Asia. Co.'s testing services include the following: Cytogenetics (karyotype analysis), a study of chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization, a molecular cytogenetic technique that focuses on detecting and localizing the presence or absence of specific DNA sequences and genes on chromosomes; Flow cytometry, a technique utilized to measure the characteristics of cell populations; Immunohistochemistry and Digital Imaging; Molecular testing; and Morphologic analysis, a process of analyzing cells under the microscope.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
1,049 |
9,748 |
12,417 |
12,417 |
| Total Sell Value |
$16,511 |
$152,803 |
$201,886 |
$201,886 |
| Total People Sold |
1 |
2 |
2 |
2 |
| Total Sell Transactions |
1 |
3 |
4 |
4 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Balliet Jennifer |
VP and Chief Culture Officer |
• – – |
2020-08-03 |
4 |
S |
$39.25 |
$510,250 |
D/D |
(13,000) |
24,980 |
|
-35% |
|
| Balliet Jennifer |
VP and Chief Culture Officer |
• – – |
2020-08-03 |
4 |
OE |
$7.52 |
$97,760 |
D/D |
13,000 |
37,980 |
|
- |
|
| Van Oort Douglas M |
Chairman and CEO |
• • – |
2020-08-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,953) |
2,287,790 |
|
- |
|
| Shovlin Robert J. |
President, Clinical Services |
• – – |
2020-07-30 |
4 |
S |
$38.17 |
$3,105,359 |
D/D |
(81,356) |
148,270 |
|
-31% |
|
| Shovlin Robert J. |
President, Clinical Services |
• – – |
2020-07-30 |
4 |
OE |
$7.52 |
$829,126 |
D/D |
83,391 |
229,626 |
|
- |
|
| Kelly Michael Aaron |
Director |
– • – |
2020-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,782 |
1,782 |
|
- |
|
| Dieter Cynthia J |
Chief Accounting Officer |
• – – |
2020-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
605 |
605 |
|
- |
|
| Stahler Rachel A |
Director |
– • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,698 |
2,698 |
|
- |
|
| Hannah Alison L. |
Director |
– • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,698 |
78,796 |
|
- |
|
| Hipp Raymond R |
Director |
– • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,698 |
136,800 |
|
- |
|
| Johnson Kevin C |
Director |
– • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,698 |
55,666 |
|
- |
|
| Jones Steven C |
Director |
– • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,698 |
197,932 |
|
- |
|
| Tetrault Lynn A. |
Director |
– • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,698 |
44,351 |
|
- |
|
| Kanovsky Stephen M |
Director |
– • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,698 |
6,117 |
|
- |
|
| Crowther Bruce K |
Director |
– • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,698 |
48,883 |
|
- |
|
| Van Oort Douglas M |
Chairman and CEO |
• • – |
2020-05-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,330) |
2,293,743 |
|
- |
|
| Shovlin Robert J. |
President, Clinical Services |
• – – |
2020-05-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,405) |
146,235 |
|
- |
|
| Crowther Bruce K |
Director |
– • – |
2020-05-01 |
4 |
OE |
$4.78 |
$47,800 |
D/D |
10,000 |
46,185 |
|
- |
|
| Jones Steven C |
Director |
– • – |
2020-03-13 |
4 |
OE |
$4.78 |
$597,500 |
I/I |
125,000 |
1,500,000 |
|
- |
|
| Shovlin Robert J. |
President, Clinical Services |
• – – |
2020-03-04 |
4 |
S |
$30.86 |
$3,027,150 |
D/D |
(98,093) |
151,640 |
|
-13% |
|
| Shovlin Robert J. |
President, Clinical Services |
• – – |
2020-03-04 |
4 |
OE |
$8.03 |
$772,221 |
D/D |
96,167 |
249,733 |
|
- |
|
| Jones Steven C |
Director |
– • – |
2020-03-02 |
4 |
S |
$28.24 |
$8,554,252 |
I/I |
(297,300) |
30,476 |
|
-22% |
|
| Mckenzie Kathryn B |
Chief Financial Officer |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,824 |
7,929 |
|
- |
|
| Shovlin Robert J. |
President, Clinical Services |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,736 |
153,566 |
|
- |
|
| Weiss Lawrence Martin |
Chief Medical Officer |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,824 |
11,717 |
|
- |
|
544 Records found
|
|
Page 8 of 22 |
|
|
0.12 (0.91%) 
